Dear Sir, Please find certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended 31st March, 2025.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Omkar Pharmachem Ltd has submitted a routine compliance certificate to BSE for the quarter ending March 31, 2025, as required under Regulation 74(5) of SEBI's Depositories and Participants Regulations. The certificate was issued by Alankit Assignments Limited, the company's Registrar and Share Transfer Agent (RTA). It confirms that all shares received from depository participants for demat during the quarter were properly processed and confirmed to the depositories. It also confirms that physical share certificates received were mutilated, cancelled, and the depository's name was substituted as the registered owner in the company's records within the prescribed timeline. No specific share counts or financial figures are disclosed in this filing.
This is a standard regulatory compliance filing with no material impact on the company's financials, operations, or stock price. It only confirms that routine share dematerialization activities for the January–March 2025 quarter were completed on time.